MP:0000685 | abnormal immune system morphology | "morphological anomalies in the organs or cells associated with the development and formation of lymphocytes" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Hmga2tm1Cha/Hmga2tm1Cha,Lepob/Lepob Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J
|
MP:0001191 | abnormal skin condition | "anomalous state of the skin" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1+ Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0001573 | abnormal circulating alanine transaminase level | "aberrent concentration in the blood of this enzyme, whcih transfers amino groups from l-alanine to 2-ketoglutarate, or the reverse (from l-glutamate to pyruvate); serum concentration is increased in viral hepatitis and myocardial infarction" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+,Tg(Mx1-cre)1Cgn/? Genetic Background: involves: 129S1/Sv * C57BL/6 * CBA
|
MP:0001790 | abnormal immune system physiology | "deviation from the normal function of the immune system " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Hmga2tm1Cha/Hmga2tm1Cha,Lepob/Lepob Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J
|
MP:0002020 | increased tumor incidence | "greater than average number of tumors, usually a specific type" [MGI:cls, J:34193] |
Show
Allelic Composition: Rag1coln/Rag1coln Genetic Background: C57BL/6JAnu-Rag1coln/Apb
Allelic Composition: Irf1tm1Mak/Irf1tm1Mak,Trp53tm1Sia/Trp53tm1Sia Genetic Background: involves: 129S2/SvPas * C57BL/6 * CBA
|
MP:0002083 | premature death | "death after 3 weeks of age, but before normal life span" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1tm1Mak Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1+ Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
Allelic Composition: Irf1tm1Mak/Irf1tm1Mak,Trp53tm1Sia/Trp53tm1Sia Genetic Background: involves: 129S2/SvPas * C57BL/6 * CBA
|
MP:0002169 | no phenotype detected | "normal, viable and fertile appearance and behavior; indistinguishable from controls" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Dnmt1tm1Okan/Dnmt1tm2Enl Genetic Background: involves: 129S4/SvJae
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Hmga2tm1Cha/Hmga2tm1Cha,Lepob/Lepob Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J
Allelic Composition: Irf1M1Btlr/Irf1M1Btlr Genetic Background: C57BL/6J-Irf1M1Btlr
Allelic Composition: Irf1M1Btlr/Irf1+ Genetic Background: C57BL/6J-Irf1M1Btlr
|
MP:0002451 | abnormal macrophage physiology | "abnormal function or response of the phagocytic leukocytes involved in innate immunity, early non-adaptive phases of host-defense, antigen presentation, and which act as effector cells in humoral and cell-mediated immunity" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Hmga2tm1Cha/Hmga2tm1Cha,Lepob/Lepob Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J
|
MP:0002490 | abnormal circulating immunoglobulin concentration | "deviation from the normal levels of glycoproteins present in the blood and other tissue, often functioning as antibodies" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Hmga2tm1Cha/Hmga2tm1Cha,Lepob/Lepob Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J
|
MP:0002627 | teratoma | "neoplasms composed of multiple tissue types; includes types not found in tissue in which lesion arises" [pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator, Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Irf1tm1Mak/Irf1tm1Mak,Trp53tm1Sia/Trp53tm1Sia Genetic Background: involves: 129S2/SvPas * C57BL/6 * CBA
|
MP:0002743 | glomerulonephritis | "glomerular disease characterized by diffuse inflammatory reaction that is not the acute response to infection of the kidneys" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1tm1Mak Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1+ Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0002962 | increased protein excretion | "greater than the normal amount of serum proteins voided by the kidneys" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1+ Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0003009 | abnormal cytokine secretion | "impairment or increase of the cellular release of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells " [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, smb:Susan M. Bello , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1tm1Mak Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0003436 | resistance to induced arthritis | "less likely to be striken with changes in the synovial membranes and thickening of articular structures, widespread degeneration of the collagen fibers in connective tissues, and by atrophy and rarefaction of bony structures that are induced by inflammatory responses caused by chemical or mechanical agents" [anna:Anna Anagnostopoulos, Mouse Genome Informatics Curator, J:75303] |
Show
Allelic Composition: Hmga2tm1Cha/Hmga2tm1Cha,Lepob/Lepob Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J
|
MP:0003667 | hemangiosarcoma | "a malignant tumor characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and appear as irregular blood-filled or lumpy sacs that are typically filled with blood; rupture of the tumor can cause rapid death from bleeding" [MeSH:National Library of Medicine - Medical Subject Headings , 2003, Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, anna:Anna Anagnostopoulos, Mouse Genome Informatics Curator, J:53511] |
Show
Allelic Composition: Rag1coln/Rag1coln Genetic Background: C57BL/6JAnu-Rag1coln/Apb
Allelic Composition: Irf1tm1Mak/Irf1tm1Mak,Trp53tm1Sia/Trp53tm1Sia Genetic Background: involves: 129S2/SvPas * C57BL/6 * CBA
|
MP:0003945 | abnormal lymphocyte physiology | "abnormal function of any of the white blood cells that includes B cells, T cells, and NK cells " [monikat:Monika Tomczuk, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+,Tg(Mx1-cre)1Cgn/? Genetic Background: involves: 129S1/Sv * C57BL/6 * CBA
|
MP:0004499 | increased incidence of chemically-induced tumors | "higher than normal frequency of tumor incidence induced by one or more chemical carcinogens or mutagens" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+,Tg(Mx1-cre)1Cgn/? Genetic Background: involves: 129S1/Sv * C57BL/6 * CBA
|
MP:0004762 | increased anti-double stranded DNA antibody level | "increase in the level of antibodies that recognize double stranded DNA" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1+ Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0004798 | decreased anti-double stranded DNA antibody level | "reduced level of antibodies to double stranded DNA present in the sera" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1tm1Mak Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0004800 | decreased susceptibility to experimental autoimmune encephalomyelitis | "reduced likelihood that an organism will develop disease symptoms similar to human multiple sclerosis upon induction with antigens to Myelin Basic Protein (MBP), Proteolipid Protein (PLP), and/or Myelin Oligodendrocyte glycoprotein (MOG)" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0004883 | abnormal blood vessel healing | "anomaly in the repair process of blood vessels after injury" [MGI:monikat "Monika Tomczuk, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Trp53tm1Mlh/Trp53tm1Mlh Genetic Background: involves: 129P2/OlaHsd
|
MP:0005025 | response to infection | "the body s reaction to invasion and multiplication of microorganisms in its tissues, or the body s reaction to components of or toxins produced by pathogenic mircroorganisms " [MeSH:National Library of Medicine - Medical Subject Headings , 2003, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Inhbbtm1Jae/Inhbbtm1Jae Genetic Background: either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)
|
MP:0005070 | defective NK cell cytolysis | "impaired ability of these cells to destroy or dissolve targeted cells" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:6213] |
Show
Allelic Composition: Irf1M1Btlr/Irf1M1Btlr Genetic Background: C57BL/6J-Irf1M1Btlr
Allelic Composition: Irf1M1Btlr/Irf1+ Genetic Background: C57BL/6J-Irf1M1Btlr
|
MP:0005091 | increased double-positive T cell count | "greater than the expected number of the subset of T cells found in the thymus that express both CD4 and CD8" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Inhbbtm1Jae/Inhbbtm1Jae Genetic Background: either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)
|
MP:0005094 | abnormal T cell proliferation | "anomaly in the clonal expansion of naive T cells" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0005621 | abnormal cell physiology | "aberration in the vital processes of the cell " [Stedman s Medical Dictionary:ISBN 0-683-40008-8, hdene:Howard Dene , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1tm1Mak Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0006387 | abnormal T cell number | "deviation from the normal count of T cells" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Inhbbtm1Jae/Inhbbtm1Jae Genetic Background: either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)
|
MP:0008037 | abnormal T cell morphology | "any structural anomaly of lymphocytes that are responsible for cell-mediated immunity and immune system regulation" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Hmga2tm1Cha/Hmga2tm1Cha,Lepob/Lepob Genetic Background: involves: 129S7/SvEvBrd * C57BL/6J
|
MP:0008045 | decreased NK cell number | "reduction in the number of non-T, non-B lymphocytes, having a granular morphology and which are important in innate immunity to viruses and other intracellular pathogens; in addition, these cells can kill certain tumor cells" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease"] |
Show
Allelic Composition: Irf1M1Btlr/Irf1M1Btlr Genetic Background: C57BL/6J-Irf1M1Btlr
Allelic Composition: Irf1M1Btlr/Irf1+ Genetic Background: C57BL/6J-Irf1M1Btlr
|
MP:0008058 | abnormal DNA repair | "any anomaly in the process of restoring DNA after damage or replication error" [GO:0006281] |
Show
Allelic Composition: Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+,Tg(Mx1-cre)1Cgn/? Genetic Background: involves: 129S1/Sv * C57BL/6 * CBA
|
MP:0008074 | increased CD4-positive T cell number | "greater number of the subset of T lymphocytes that carry the CD4 marker, recognize intravesicular peptides bound to MHC class-II molecules, and turn on antibody production" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Inhbbtm1Jae/Inhbbtm1Jae Genetic Background: either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1tm1Mak Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
Allelic Composition: Faslpr/Faslpr,Irf1tm1Mak/Irf1+ Genetic Background: MRL.Cg-Irf1tm1Mak Faslpr
|
MP:0008079 | decreased CD8-positive T cell number | "reduction in the number of the regulatory subset of T lymphocytes that are involved in MHC class I restricted interactions" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Inhbbtm1Jae/Inhbbtm1Jae Genetic Background: either: (129S4/SvJae-Inhbbtm1Jae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
Allelic Composition: Irf1M1Btlr/Irf1M1Btlr Genetic Background: C57BL/6J-Irf1M1Btlr
Allelic Composition: Irf1M1Btlr/Irf1+ Genetic Background: C57BL/6J-Irf1M1Btlr
|
MP:0008090 | increased T-helper 2 cell number | "greater number of the subset of the type of T-helper cell whose cytokine production promotes defense against extracellular parasites and humoral immune responses typical of allergy" [CL:0000546, ISBN:0781735149, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008563 | decreased interferon-alpha secretion | "increase in the production or release of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Irf1M1Btlr/Irf1M1Btlr Genetic Background: C57BL/6J-Irf1M1Btlr
|
MP:0008565 | decreased interferon-beta secretion | "reduction in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Irf1M1Btlr/Irf1M1Btlr Genetic Background: C57BL/6J-Irf1M1Btlr
|
MP:0008567 | decreased interferon-gamma secretion | "reduction in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+,Tg(Mx1-cre)1Cgn/? Genetic Background: involves: 129S1/Sv * C57BL/6 * CBA
|
MP:0008577 | increased circulating interferon-gamma level | "increase in the amount in the blood of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008578 | decreased circulating interferon-gamma level | "reduction in the amount in the blood of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008590 | abnormal circulating interleukin-10 level | "anomaly in the amount in the blood of a cytokine produced by a variety of cell types, including T-cells, monocytes, dendritic cells and epithelial cells that exerts a variety of effects on immunoregulation and inflammation" [MESH:D12.644.276.374.465.510] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008596 | increased circulating interleukin-6 level | "increase in the amount in the blood of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008600 | decreased circulating interleukin-2 level | "reduction in the amount in the blood of a soluble substance elaborated by antigen- or mitogen-stimulated T-cells which induces DNA synthesis in naive lymphocytes" [MESH:D12.644.276.374.465.502] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008601 | abnormal circulating interleukin-4 level | "anomaly in the amount in the blood of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv
|
MP:0008602 | increased circulating interleukin-4 level | "increase in the amount in the blood of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008608 | increased circulating interleukin-13 level | "increase in the amount in the blood of a cytokine synthesized by T-cells that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-cells, and appears to play a role in regulating inflammatory and immune responses" [MESH:D12.644.276.374.465.513] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv
|
MP:0008623 | increased circulating interleukin-3 level | "increase in the amount in the blood of a multilineage cell growth factor secreted by lymphocytes, epithelial cells and astrocytes which stimulates clonal proliferation and differentiation of various types of blood and tissue cells" [MESH:D12.644.276.374.410.240.400] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008626 | increased circulating interleukin-5 level | "increase in the amount in the blood of a cytokine that promotes differentiation and activation of eosinophils; it also triggers activated B-cells to differentiate into immunoglobulin-secreting cells" [MESH:D12.644.276.374.465.505] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008713 | abnormal cytokine level | "deviation from the normal levels of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0008827 | abnormal thymus cell ratio | "deviation from the standard ratios of thymocyte subpopulations compared to control samples" [MGI:mberry "Melissa Berry, Genetics Resources Curator"] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0009332 | abnormal splenocyte morphology | "any structural anomaly of a cell of the spleen" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Irf1tm1Cwe/Irf1tm1Cwe Genetic Background: involves: 129/Sv * C57BL/6
|
MP:0009766 | increased sensitivity to xenobiotic induced morbidity/mortality | "decrease in the amount of a foreign compound required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+,Tg(Mx1-cre)1Cgn/? Genetic Background: involves: 129S1/Sv * C57BL/6 * CBA
|
MP:0012431 | increased lymphoma incidence | "greater than the expected number of neoplasms characterized by a proliferation of malignant lymphocytes in lymphoid tissue in a specific population in a given time period" [http://orcid.org/0000-0001-5208-3432, MGI:csmith] |
Show
Allelic Composition: Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+,Tg(Mx1-cre)1Cgn/? Genetic Background: involves: 129S1/Sv * C57BL/6 * CBA
Allelic Composition: Irf1tm1Mak/Irf1tm1Mak,Trp53tm1Sia/Trp53tm1Sia Genetic Background: involves: 129S2/SvPas * C57BL/6 * CBA
|